Related Experiment Video

Updated: Aug 29, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

[Tuberous sclerosis and cardiac tumor (case report)]

L Haddour1, N Haddour, N Doghmi

  • 1Service de cardiologie BCH, 12, rue Cadi Benbrahim Pinede Souissi, Ibn Sina Rabat, Maroc. lailahaddour@wanadoo.net.ma

Annales De Cardiologie Et D'Angeiologie
|February 3, 2004
PubMed

Insights

Tuberous sclerosis, an inherited disorder, frequently causes cardiac rhabdomyomas in children. Early cardiac screening is crucial for managing this condition and its associated heart tumors.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Tuberous sclerosis is an autosomal dominant genetic disorder.
  • It is associated with the development of benign tumors in various organs, including the heart.
  • Cardiac rhabdomyomas are the most common cardiac tumors in infants and children.

Observation:

  • A case study of an 11-year-old girl with tuberous sclerosis is presented.
  • A cardiac tumor was incidentally discovered during a routine cardiac examination.
  • This highlights the importance of comprehensive examinations in patients with tuberous sclerosis.

Findings:

  • Tuberous sclerosis is linked to cardiac rhabdomyomas in over 50% of cases.
  • Cardiac rhabdomyomas can be multiple and are often detected prenatally.
  • Approximately 60% of cardiac rhabdomyomas occur in the context of tuberous sclerosis.

Implications:

  • Systematic cardiac evaluation is essential for individuals diagnosed with tuberous sclerosis.
  • Early detection of cardiac rhabdomyomas can guide timely management and improve patient outcomes.
  • Increased prenatal diagnosis of cardiac rhabdomyomas via fetal echocardiography is noted.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...